ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections.

Namei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.